Estrogenic mediation of serotonergic and neurotrophic systems: Implications for female mood disorders

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 54, Issue , 2014, Pages 13-25

  Borrow, Amanda P ^a   Cameron, Nicole M ^a  

^a BINGHAMTON UNIVERSITY   (United States)

Author keywords

BDNF; Brain; Depression; Estrogen; Female; Menstrual; Perimenopause; Postpartum; Serotonin; Women

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; BRAIN DERIVED NEUROTROPHIC FACTOR; DROSPIRENONE; ESTRADIOL; ESTROGEN; ETHINYLESTRADIOL; GONADORELIN AGONIST; NEUROTROPHIN 4; PAROXETINE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; TRYPTOPHAN HYDROXYLASE; NERVE GROWTH FACTOR; SEROTONIN;

AMYGDALOID NUCLEUS; ANTERIOR CINGULATE; DEPRESSION; DRUG EFFICACY; DRUG MECHANISM; FEAR; HIPPOCAMPUS; HORMONAL THERAPY; HUMAN; INVOLUTIONAL DEPRESSION; MAJOR DEPRESSION; MENOPAUSE; MENSTRUAL CYCLE; MONOTHERAPY; MOOD DISORDER; NONHUMAN; PERIMENOPAUSAL DEPRESSION; PREFRONTAL CORTEX; PREMENSTRUAL DYSPHORIC DISORDER; PROTEIN BLOOD LEVEL; PUERPERAL DEPRESSION; RAPHE NUCLEUS; REVIEW; SEROTONINERGIC SYSTEM; SPATIAL MEMORY; UNSPECIFIED SIDE EFFECT; VENOUS THROMBOEMBOLISM; ANIMAL; BRAIN; FEMALE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; BRAIN; ESTROGENS; FEMALE; HUMANS; MOOD DISORDERS; NERVE GROWTH FACTORS; SEROTONIN;

EID: 84902509362     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2014.05.009     Document Type: Review

References (217)

1. Abraham G.E., Odell W.D., Swerdloff R.S., Hopper K. Simultaneous radioimmunoassay of plasma FSH, LH, progesterone, 17-hydroxyprogesterone, and estradiol-17 beta during the menstrual cycle. J Clin Endocrinol Metab 1972, 34:312-318.
2. Ahokas A.J., Turtiainen S., Aito M. Sublingual oestrogen treatment of postnatal depression. Lancet 1998, 351:109.
3. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2013, American Psychiatric Publishing, Arlington, VA. 5th ed.
4. Amin Z., Epperson C.N., Constable R.T., Canli T. Effects of estrogen variation on neural correlates of emotional response inhibition. Neuroimage 2006, 32:457-464.
5. Angelucci F., Aloe L., Vasquez P.J., Mathé A.A. Mapping the differences in the brain concentration of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in an animal model of depression. Neuroreport 2000, 11:1369-1373.
6. Arango V., Underwood M.D., Mann J.J. Serotonin brain circuits involved in major depression and suicide. Prog Brain Res 2002, 136:443-453.
7. Austin M.C., Bradley C.C., Mann J.J., Blakely R.D. Expression of serotonin transporter messenger RNA in the human brain. J Neurochem 1994, 62:2362-2367.
8. Azmitia E.C., Segal M. An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J Comp Neurol 1978, 179:641-667.
9. Bach-Mizrachi H., Underwood M.D., Tin A., Ellis S.P., Mann J.J., Arango V. Elevated expression of tryptophan hydroxylase-2 mRNA at the neuronal level in the dorsal and median raphe nuclei of depressed suicides. Mol Psychiatry 2008, 13:507-513.
10. Bao A.M., Meynen G., Swaab D.F. The stress system in depression and neurodegeneration: focus on the human hypothalamus. Brain Res Rev 2008, 57:531-553.
11. Barouk S., Hintz T., Li P., Duffy A.M., MacLusky N.J., Scharfman H.E. 17β-Estradiol increases astrocytic vascular endothelial growth factor (VEGF) in adult female rat hippocampus. Endocrinology 2011, 152:1745-1751.
12. Begliuomini S., Casarosa E., Pluchino N., Lenzi E., Centofanti M., Freschi L., et al. Influence of endogenous and exogenous sex hormones on plasma brain-derived neurotrophic factor. Hum Reprod 2007, 22:995-1002.
13. Bekinschtein P., Cammarota M., Izquierdo I., Medina J.H. Reviews: BDNF and memory formation and storage. Neuroscientist 2008, 14:147-156.
14. Benmansour S., Deltheil T., Piotrowski J., Nicolas L., Reperant C., Gardier A.M., et al. Influence of brain-derived neurotrophic factor (BDNF) on serotonin neurotransmission in the hippocampus of adult rodents. Eur J Pharmacol 2008, 587:90-98.
15. Benmansour S., Piotrowski J.P., Altamirano A.V., Frazer A. Impact of ovarian hormones on the modulation of the serotonin transporter by fluvoxamine. Neuropsychopharmacology 2009, 34:555-564.
16. Benmansour S., Weaver R.S., Barton A.K., Adeniji O.S., Frazer A. Comparison of the effects of estradiol and progesterone on serotonergic function. Biol Psychiatry 2012, 71:633-641.
17. Bertrand P.P., Paranavitane U.T., Chavez C., Gogos A., Jones M., van den Buuse M. The effect of low estrogen state on serotonin transporter function in mouse hippocampus: a behavioral and electrochemical study. Brain Res 2005, 1064:10-20.
18. Bethea C.L., Mirkes S.J., Shively C.A., Adamas M.R. Steroid regulation of tryptophan hydroxylase protein in the dorsal raphe of macaques. Biol Psychiatry 2000, 47:562-576.
19. Bethea C.L., Smith A.W., Centeno M.L., Reddy A.P. Long-term ovariectomy decreases serotonin neuron number and gene expression in free ranging macaques. Neuroscience 2011, 192:675-688.
20. Bigos K.L., Pollock B.G., Stankevich B.A., Bies R.R. Sex differences in the pharmacokinetics and pharmacodynamics of antidepressants: an updated review. Gend Med 2009, 6:522-543.
21. Bird S.T., Delaney J.A., Etminan M., Brophy J.M., Hartzema A.G. Drospirenone and non-fatal venous thromboembolism: is there a risk difference by dosage of ethinyl-estradiol?. J Thromb Haemost 2013, 11:1059-1068.
22. Bloch M., Schmidt P.J., Danaceau M., Murphy J., Nieman L., Rubinow D.R. Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry 2000, 157:924-930.
23. Bloch M., Daly R.C., Rubinow D.R. Endocrine factors in the etiology of postpartum depression. Compr Psychiatry 2003, 44:234-246.
24. Bloch M., Rotenberg N., Koren D., Klein E. Risk factors for early postpartum depressive symptoms. Gen Hosp Psychiatry 2006, 28:3-8.
25. Bocchio-Chiavetto L., Bagnardi V., Zanardini R., Molteni R., Nielsen M.G., Placentino A., et al. Serum and plasma BDNF levels in major depression: a replication study and meta-analyses. World J Biol Psychiatry 2010, 11:763-773.
26. Boldrini M., Underwood M.D., Hen R., Rosoklija G.B., Dwork A.J., John Mann J., et al. Antidepressants increase neural progenitor cells in the human hippocampus. Neuropsychopharmacology 2009, 34:2376-2389.
27. Bonkale W.L., Murdock S., Janosky J.E., Austin M.C. Normal levels of tryptophan hydroxylase immunoreactivity in the dorsal raphe of depressed suicide victims. J Neurochem 2004, 88:958-964.
28. Bora E., Fornito A., Pantelis C., Yücel M. Gray matter abnormalities in major depressive disorder: a meta-analysis of voxel based morphometry studies. J Affect Disord 2012, 138:9-18.
29. 1A autoreceptors evokes strong anti-depressant-like effects. Mol Psychiatry 2012, 17:612-623.
30. Brinton R.D. Translational animal models of human menopause: challenges and emerging opportunities. Endocrinology 2012, 153:3571-3578.
31. Brown J., O'Brien P.M., Marjoribanks J., Wyatt K. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev 2009, CD001396.
32. 2A receptor mRNA in the human brain. Brain Res 1995, 676:157-168.
33. Bush G., Luu P., Posner M.I. Cognitive and emotional influences in anterior cingulate cortex. Trends Cogn Sci 2000, 4:215-222.
34. 1A receptors in rat brain. Neuropharmacology 2003, 44:93-101.
35. 2A agonist treatment on brain-derived neurotrophic factor expression in female rats. Biol Psychiatry 2003, 54:56-69.
36. Chang A.S., Chang S.M. Nongenomic steroidal modulation of high-affinity serotonin transport. Biochim Biophys Acta 1999, 1417:157-166.
37. Charoenphandhu J., Teerapornpuntakit J., Nuntapornsak A., Krishnamra N., Charoenphandhu N. Anxiety-like behaviors and expression for SERT and THP in the dorsal raphé of estrogen- and fluoxetine-treated ovariectomized rats. Pharmacol Biochem Behav 2011, 98:503-510.
38. Cheetham S.C., Crompton M.R., Czudek C., Horton R.W., Katona C.L.E., Reynolds G.P. Serotonin concentrations and turnover in brains of depressed suicides. Brain Res 1989, 502:332-340.
39. 1 binding sites in depressed suicides. Psychopharmacology (Berl) 1990, 102:544-548.
40. Chrousos G.P., Torpy D.J., Gold P.W. Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive system: clinical implications. Ann Intern Med 1998, 129:229-240.
41. Conner J.M., Lauterborn J.C., Yan Q., Gall C.M., Varon S. Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport. J Neurosci 1997, 17:2295-2313.
42. Cotter D., Mackay D., Landau S., Kerwin R., Everall I. Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch Gen Psychiatry 2001, 58:545-553.
43. Craig M.C., Fletcher P.C., Daly E.M., Rymer J., Cutter W.J., Brammer M., et al. Gonadotropin hormone releasing hormone agonists alter prefrontal function during verbal encoding in young women. Psychoneuroendocrinology 2007, 32:1116-1127.
44. Daftary S.S., Calderon G., Rios M. Essential role of brain-derived neurotrophic factor in the regulation of serotonin transmission in the basolateral amygdala. Neuroscience 2012, 224:125-134.
45. Davanzo R., Copertino M., De Cunto A., Minen F., Amaddeo A. Antidepressant drugs and breastfeeding: a review of the literature. Breastfeed Med 2011, 6:89-98.
46. Davidson R.J., Pizzagalli D., Nitschke J.B., Putnam K. Depression: perspectives from affective neuroscience. Annu Rev Psychol 2002, 53:545-574.
47. De Hertogh R., Thomas K., Bietlot Y., Vanderheyden I., Ferin J. Plasma levels of unconjugated estrone, estradiol and estriol and of HCS throughout pregnancy in normal women. J Clin Endocrinol Metab 1975, 40:93-101.
48. Deltheil T., Guiard B.P., Cerdan J., David D.J., Tanaka K.F., Repérant C., et al. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice. Neuropharmacology 2008, 55:1006-1014.
49. Di Paolo T., Diagle M., Picard V., Barden N. Effect of acute and chronic 17β-estradiol treatment on serotonin and 5-hydroxyindole acetic acid content of discrete brain nuclei of ovariectomized rat. Exp Brain Res 1983, 51:73-76.
50. Donner N., Handa R.J. Estrogen receptor beta regulates the expression of tryptophan hydroxylase 2 mRNA within the serotonergic neurons of the rat dorsal raphe nuclei. Neuroscience 2009, 163:705-718.
51. 1A receptors in the dorsal hippocampus mediate the anxiogenic effect induced by the stimulation of 5-HT neurons in the median raphe nucleus. Eur Neuropsychopharmacol 2008, 18:286-294.
52. Douma S.L., Husband C., O'Donnell M.E., Barwin B.N. Estrogen-related mood disorders: reproductive life cycle factors. ANS Adv Nurs Sci 2005, 28:364-375.
53. Drevets W.C., Thase M.E., Moses-Kolko E.L., Price J., Frank E., Kupfer D.J., et al. Serotonin-1A receptor imaging in recurrent depression: replication and literature review. Nucl Med Biol 2007, 34:865-877.
54. Dwivedi Y., Rizavi H.S., Conley R.R., Roberts R.C., Tamminga C.A., Pandey G.N. Altered gene expression of brain-derived neurotrophin factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry 2003, 60:804-815.
55. Dwivedi Y., Rizavi H.S., Zhang H., Roberts R.C., Conley R.R., Pandey G.N. Aberrant extracellular signal-regulated kinase (ERK)1/2 signalling in suicide brain: role of ERK kinase 1 (MEK1). Int J Neuropsychopharmacol 2009, 12:1337-1354.
56. Eastwood S.L., Harrison P.J. Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a Western blot study of synaptophysin, GAP-43, and the complexins. Brain Res Bull 2001, 55:569-578.
57. Engler-Chiurazzi E., Tsang C., Nonnenmacher S., Liang W.S., Corneveaux J.J., Prokai L., et al. Tonic Premarin dose-dependently enhances memory, affects neurotrophin protein levels and alters gene expression in middle-aged rats. Neurobiol Aging 2011, 32:680-697.
58. Etkin A., Egner T., Peraza D.M., Kandel E.R., Hirsch J. Resolving emotional conflict: a role for the rostral anterior cingulate cortex in modulating activity in the amygdala. Neuron 2006, 51:871-882.
59. Fan L., Zhao Z., Orr P.T., Chambers C.H., Lewis M.C., Frick K.M. Estradiol-induced object memory consolidation in middle-aged female mice requires dorsal hippocampal extracellular signal-regulated kinase and phosphatidylinositol 3-kinase activation. J Neurosci 2010, 30:4390-4400.
60. Fernandez S.M., Lewis M.C., Pechenino A.S., Harburger L.L., Orr P.T., Gresack J.E., et al. Estradiol-induced enhancement of object memory consolidation involves hippocampal extracellular signal-regulated kinase activation and membrane-bound estrogen receptors. J Neurosci 2008, 28:8660-8667.
61. Fink G., Sumner B.E., Rosie R., Grace O., Quinn J.P. Estrogen control of central neurotransmission: effect on mood, mental state, and memory. Cell Mol Neurobiol 1996, 16:325-344.
62. First M., Gil-Ad I., Taler M., Tarasenko I., Novak N., Weizman A. The effects of fluoxetine treatment in a chronic mild stress rat model on depression-related behavior, brain neurotrophins and ERK expression. J Mol Neurosci 2011, 45:246-255.
63. Fitzgerald P.B., Srithiran A., Benitez J., Daskalakis Z.Z., Oxley T.J., Kulkarni J., et al. An fMRI study of prefrontal brain activation during multiple tasks in patients with major depressive disorder. Hum Brain Mapp 2008, 29:490-501.
64. Flores D.L., Hendrick V.C. Etiology and treatment of postpartum depression. Curr Psychiatry Rep 2002, 4:461-466.
65. Frazer A., Hensler J.G. Serotonin. Basic neurochemistry: molecular, cellular and medical aspects 1998, 263-292. Lippincott Williams & Wilkins, Philadelphia. 6th Ed. G.J. Siegel, B.W. Agranoff, R.W. Albers, S.K. Fisher, M.D. Uhler (Eds.).
66. Freeman E.W., Sammel M.D., Lin H., Nelson D.B. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry 2006, 63:375-382.
67. Frodl T., Meisenzahl E., Zetzsche T., Bottlender R., Born C., Groll C., et al. Enlargement of the amygdala in patients with a first episode of major depression. Biol Psychiatry 2002, 51:708-714.
68. Gatson J.W., Liu M.M., Abdelfattah K., Wigginton J.G., Smith S., Wolf S., et al. Estrone is neuroprotective in rats after traumatic brain injury. J Neurotrauma 2012, 29:2209-2219.
69. Gibbs R.B. Long-term treatment with estrogen and progesterone enhances acquisition of a spatial memory task by ovariectomized aged rats. Neurobiol Aging 2000, 21:107-116.
70. Gingnell M., Morell A., Bannbers E., Wikström, Sundström Poromaa I.S. Menstrual cycle effects on amygdala reactivity to emotional stimulation in premenstrual dysphoric disorder. Horm Behav 2012, 62:400-406.
71. Godlewska B.R., Norbury R., Selvaraj S., Cowen P.J., Harmer C.J. Short-term SSRI treatment normalises amygdala hyperactivity in depressed patients. Psychol Med 2012, 42:2609-2617.
72. Goldstein J.M., Jerram M., Poldrack R., Ahern T., Kennedy D.N., Seidman L.J., et al. Hormonal cycle modulates arousal circuitry in women using functional magnetic resonance imaging. J Neurosci 2005, 25:9309-9316.
73. Gould E., Woolley C.S., Frankfurt M., McEwen B.S. Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood. J Neurosci 1990, 10:1286-1291.
74. Green A.D., Galea L.A. Adult hippocampal cell proliferation is suppressed with estrogen withdrawal after a hormone-simulated pregnancy. Horm Behav 2008, 54:203-211.
75. Gregoire A.J., Kumar R., Everitt B., Henderson A.F., Studd J.W. Transdermal oestrogen for treatment of severe postnatal depression. Lancet 1996, 347:930-933.
76. Grigorova M., Sherwin B.B., Tulandi T. Effects of treatment with leuprolide acetate depot on working memory and executive functions in young premenopausal women. Psychoneuroendocrinology 2006, 31:935-947.
77. Gruber C.J., Tschugguel W., Schneeberger C., Huber J.C. Production and actions of estrogens. N Engl J Med 2002, 346:340-352.
78. Guilloux J.P., Douillard-Guilloux G., Kota R., Wang X., Gardier A.M., Martinowich K., et al. Molecular evidence for BDNF- and GABA-related dysfunctions in the amygdala of female subjects with major depression. Mol Psychiatry 2011, 17:1130-1142.
79. Gundlah C., Lu N.Z., Mirkes S.J., Bethea C.L. Estrogen receptor beta (ERβ) mRNA and protein in serotonin neurons of macaques. Brain Res Mol Brain Res 2001, 91:14-22.
80. Hao J., Rapp P.R., Leffler A.E., Leffler S.R., Janssen W.G.M., Lou W., et al. Estrogen alters spine number and morphology in prefrontal cortex of aged female rhesus monkeys. J Neurosci 2006, 26:2571-2578.
81. Harris E.C., Barraclough B. Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry 1997, 170:205-228.
82. Hartlage S.A., Freels S., Gotman N., Yonkers K. Criteria for premenstrual dysphoric disorder: secondary analysis of relevant data sets. Arch Gen Psychiatry 2012, 69:300-305.
83. Hasegawa S., Nishi K., Watanabe A., Overstreet D.H., Diksic M. Brain 5-HT synthesis in the Flinders Sensitive Line rat model of depression: an autoradiographic study. Neurochem Int 2006, 48:358-366.
84. Heikkinen T., Puoliváli, Liu L., Rissanen A., Tanila H. Effects of ovariectomy and estrogen treatment on learning and hippocampal neurotransmitters in mice. Horm Behav 2002, 41:22-32.
85. Henderson J.A., Bethea C.L. Differential effects of ovarian steroid and raloxifene on serotonin 1A and 2C receptor protein expression in macaques. Endocrine 2008, 33:285-293.
86. Holsen L.M., Spaeth S.B., Lee J.H., Ogden L.A., Klibanski A., Whitfield-Gabrieli S., et al. Stress response circuitry hypoactivation related to hormonal dysfunction in women with major depression. J Affect Disord 2011, 131:379-387.
87. Homung J.P. The human raphe nuclei and the serotonergic system. J Chem Neuroanat 2003, 26:331-343.
88. Imwalle D.B., Gustafsson J.A., Rissman E.F. Lack of functional estrogen receptor β influences anxiety behavior and serotonin content in female mice. Physiol Behav 2005, 84:157-163.
89. Jacome L.F., Gautreaux C., Inagaki T., Mohan G., Alves S., Lubbers L.S., et al. Estradiol and ERβ agonists enhance recognition memory, and DPN, an ERβ agonist, alters brain monoamines. Neurobiol Learn Mem 2010, 94:488-498.
90. Jezierski M.K., Sohrabji F. Region- and peptide-specific regulation of the neurotrophins by estrogen. Brain Res Mol Brain Res 2000, 85:77-84.
91. Joffe H., Hall J.E., Gruber S., Sarmiento I.A., Cohen L.S., Yurgelun-Todd D., et al. Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently postmenopausal women. Menopause 2006, 13:411-422.
92. Johnstone T., van Reekum C.M., Urry H.L., Kalin N.H., Davidson R.J. Failure to regulate: counterproductive recruitment of top-down prefrontal-subcortical circuitry in major depression. J Neurosci 2007, 27:8877-8884.
93. Keyes K.M., Cheslack-Postava K., Westhoff C., Heim C.M., Haloossim M., Walsh K., et al. Association of hormonal contraceptive use with reduced levels of depressive symptoms: a national study of sexually active women in the United States. Am J Epidemiol 2013, 178:1378-1388.
94. Kiss A., Delattre A.M., Pereira S.I., Carolino R.G., Szawka R.E., Anselmo-Franci J.A., et al. 17β-Estradiol replacement in young, adult and middle-aged female ovariectomized rats promotes improvement of spatial reference memory and an antidepressant effect and alters monoamines and BDNF levels in memory- and depression-related brain areas. Behav Brain Res 2012, 227:100-108.
95. 1a receptor binding and expression in conditional brain-derived neurotrophic factor knock-out mice. Neuroscience 2010, 169:1007-1016.
96. Konrad C., Engelien A., Schöning S., Zwitserlood P., Jansen A., Pletziger E., et al. The functional anatomy of semantic retrieval is influenced by gender, menstrual cycle, and sex hormones. J Neural Transm 2008, 115:1327-1337.
97. Kramár E.A., Babayan A.H., Gall C.M., Lynch G. Estrogen promotes learning-related plasticity by modifying the synaptic cytoskeleton. Neuroscience 2013, 239:3-16.
98. Krishnan V., Nestler E.J. The molecular neurobiology of depression. Nature 2008, 455:894-902.
99. Kronenberg G., Tebartz van Elst L., Regen F., Deuschle M., Heuser I., Colla M. Reduced amygdala volume in newly admitted psychiatric patients with unipolar major depression. J Psychiatr Res 2009, 43:1112-1117.
100. 1A receptor binding and G-protein activation in the rat brain after estrogen treatment: comparison with tamoxifen and raloxifene. J Psychiatry Neurosci 2005, 30:110-117.
101. Lee B.H., Kim H., Park S.H., Kim Y.K. Decreased plasma BDNF level in depressive patients. J Affect Disord 2007, 101:239-244.
102. Li C., Brake W.G., Romeo R.D., Dunlop J.C., Gordon M., Buzescu R., et al. Estrogen alters hippocampal dendritic spine shape and enhances synaptic protein immunoreactivity and spatial memory in female mice. Proc Natl Acad Sci U S A 2004, 101:2185-2190.
103. 1A receptors in the hippocampus and amygdala. Eur J Pharmacol 2006, 532:74-80.
104. Licht T., Goshen I., Avital A., Kreisel T., Zubedat S., Eavri R., et al. Reversible modulations of neuronal plasticity by VEGF. Proc Natl Acad Sci U S A 2011, 108:5081-5086.
105. Licznerski P., Duman R.S. Remodeling of axo-spinous synapses in the pathophysiology and treatment of depression. Neuroscience 2013, 251:33-50.
106. Liu Y., Fowler C.D., Young L.J., Yan Q., Insel T.R., Wang Z. Expression and estrogen regulation of brain-derived neurotrophic factor gene and protein in the forebrain of female prairie voles. J Comp Neurol 2001, 433:499-514.
107. 1A receptor binding sites in post-mortem brain samples from depressed suicides and controls. J Affect Disord 1997, 42:199-207.
108. 1A receptor binding and G protein activation in female monkeys. Neuropsychopharmacology 2002, 27:12-24.
109. Luine V., Attalla S., Mohan G., Costa A., Frankfurt M. Dietary phytoestrogens enhance spatial memory and spine density in the hippocampus and prefrontal cortex of ovariectomized rats. Brain Res 2006, 1126:183-187.
110. Luisi A.F., Pawasauskas J.E. Treatment of premenstrual dysphoric disorder with selective serotonin reuptake inhibitors. Pharmacotherapy 2003, 23:1131-1140.
111. Lukes A. Evolving issues in the clinical and managed care settings on the management of menopause following the women's health initiative. J Manag Care Pharm 2008, 14:7-13.
112. MacGillivray L., Lagrou L.M., Reynolds K.B., Rosebush P.I., Mazurek M.F. Role of serotonin transporter inhibition in the regulation of tryptophan hydroxylase in brainstem raphe nuclei: time course and regional specificity. Neuroscience 2010, 171:407-420.
113. Madhav T.R., Pei Q., Zetterström T.S. Serotonergic cells of the rat raphe nuclei express mRNA of tyrosine kinase B (trkB), the high-affinity receptor for brain derived neurotrophic factor (BDNF). Brain Res Mol Brain Res 2001, 93:56-63.
114. Maki P.M., Dennerstein L., Clark M., Guthrie J., LaMontagne P., Fornelli D., et al. Perimenopausal use of hormone therapy is associated with enhanced memory and hippocampal function later in life. Brain Res 2011, 1379:232-243.
115. Marr J., Heinemann K., Kunz M., Rapkin A. Ethinyl estradiol 20μg/drospirenone 3mg 24/4 oral contraceptive for the treatment of functional impairment in women with premenstrual dysphoric disorder. Int J Gynaecol Obstet 2011, 113:103-107.
116. 1A receptor signaling in the paraventricular nucleus of the rat hypothalamus. Psychoneuroendocrinology 2012, 37:1248-1260.
117. McEwen A.M., Burgess D.T., Hanstock C.C., Seres P., Khalili P., Newman S.C., et al. Increased glutamate levels in the medial prefrontal cortex in patients with postpartum depression. Neuropsychopharmacology 2012, 37:2428-2435.
118. McLaughlin K.J., Bimonte-Nelson H., Neisewander J.L., Conrad C.D. Assessment of estradiol influence on spatial tasks and hippocampal CA1 spines: evidence that the duration of hormone deprivation after ovariectomy compromises 17beta-estradiol effectiveness in altering CA1 spines. Horm Behav 2008, 54:386-395.
119. McNatty K.P., Makris A., DeGrazia C., Osathanondh R., Ryan K.J. The production of progesterone, androgens, and estrogens by granulosa cells, thecal tissue, and stromal tissue from human ovaries in vitro. J Clin Endocrinol Metab 1979, 49:687-699.
120. McQueen J.K., Wilson H., Fink G. Estradiol-17 beta increases serotonin transporter (SERT) mRNA levels and SERT-binding sites in female rat brain. Brain Res Mol Brain Res 1997, 45:13-23.
121. 3H]paroxetine binding in the cerebral cortex and dorsal hippocampus of gonadectomized male and female rats. Brain Res 1993, 601:299-302.
122. Miller K.J., Conney J.C., Rasgon N.L., Fairbanks L.A., Small G.W. Mood symptoms and cognitive performance in women estrogen users and nonusers and men. J Am Geriatr Soc 2002, 50:1826-1830.
123. Monfils M.H., Cowansage K.K., LeDoux J.E. Brain-derived neurotrophic factor: linking fear learning to memory consolidation. Mol Pharmacol 2007, 72:235-237.
124. Montague D., Weickert C.S., Tomaskovic-Crook E., Rothmond D.A., Kleinman J.E., Rubinow D.R. Oestrogen receptor alpha localisation in the prefrontal cortex of three mammalian species. J Neuroendocrinol 2008, 20:893-903.
125. Morrison M.F., Kallan M.J., Ten Have T., Katz I., Tweedy K., Battistini M. Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled study. Biol Psychiatry 2004, 55:406-412.
126. Moses-Kolko E.L., Wisner K.L., Price J.C., Berga S.L., Drevets W.C., Hanusa B.H., et al. Serotonin 1A receptor reductions in postpartum depression: a positron emission tomography study. Fertil Steril 2008, 89:685-692.
127. Moses-Kolko E.L., Perlman S.B., Wisner K.L., James J., Saul A.T., Phillips M.L. Abnormally reduced dorsomedial prefrontal cortical activity and effective connectivity with amygdala in response to negative emotional faces in postpartum depression. Am J Psychiatry 2010, 167:1373-1380.
128. Naumenko V.S., Kondaurova E.M., Bazovkina D.V., Tsybko A.S., Tikhonova M.A., Kulikov A.V., et al. Effect of brain-derived neurotrophic factor on behavior and key members of the brain serotonin system in genetically predisposed to behavioral disorders mouse strains. Neuroscience 2012, 214:59-67.
129. Nemeroff C.B. Prevalence and management of treatment-resistant depression. J Clin Psychiatry 2007, 68:17-25.
130. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., Monteggia L.M. Neurobiology of depression. Neuron 2002, 34:13-25.
131. Newberg A.B.., Amsterdam J.D., Wintering N., Shults J. Low brain serotonin transporter binding in major depressive disorder. Psychiatry Res 2012, 202:161-167.
132. Nishi K., Kanemaru K., Diksic M. A genetic rat model of depression, Flinders Sensitive Line, has a lower density of 5-HT(1A) receptors, but a higher density of 5-HT(1B) receptors, compared to control rats. Neurochem Int 2009, 54:299-307.
133. Nishizuka M., Arai Y. Synapse formation in response to estrogen in the medial amygdala developing in the eye. Proc Natl Acad Sci U S A 1982, 79:7024-7026.
134. Ossewaarde L., Hermans E.J., van Wingen G.A., Kooijman S.C., Johansson I.M., Bäckström T., et al. Neural mechanisms underlying changes in stress-sensitivity across the menstrual cycle. Psychoneuroendocrinology 2010, 35:47-55.
135. Österlund M.K., Hurd Y.L. Estrogen receptors in the human forebrain and the relation to neuropsychiatric disorders. Prog Neurobiol 2001, 64:251-267.
136. Österlund M.K., Kuiper G.G., Gustafsson J.A., Hurd Y.L. Differential distribution and regulation of estrogen receptor-alpha and -beta mRNA within the female brain. Brain Res Mol Brain Res 1998, 54:175-180.
137. Österlund M.K., Overstreet D.H., Hurd Y.L. The Flinders Sensitive Line rats, a genetic model of depression, show abnormal serotonin receptor mRNA expression in the brain that is reversed by 17β-estradiol. Brain Res Mol Brain Res 1999, 74:158-166.
138. Österlund M.K., Gustafsson J.A., Keller E., Hurd Y.L. Estrogen receptor β (ERβ) messenger ribonucleic acid (mRNA) expression within the human forebrain: distinct distribution pattern to ERα mRNA. J Clin Endocrinol Metab 2000, 85:3840-3846.
139. Österlund M.K., Halldin C., Hurd Y.L. Effects of chronic 17 beta-estradiol treatment on the serotonin 5-HT(1A) receptor mRNA and binding levels in the rat brain. Synapse 2000, 35:39-44.
140. Östlund H., Keller E., Hurd Y.L. Estrogen receptor gene expression in relation to neuropsychiatric disorders. Ann N Y Acad Sci 2003, 1007:54-63.
141. Packard M.G., Teather L.A. Intra-hippocampal estradiol infusion enhances memory in ovariectomized rats. Neuroreport 1997, 8:3009-3013.
142. Pae C.U., Mandelli L., Kim T.S., Han C., Masand P.S., Marks D.M., et al. Effectiveness of antidepressant treatments in pre-menopausal versus post-menopausal women: a pilot study on differential effects of sex hormones on antidepressant effects. Biomed Pharmacother 2009, 63:228-235.
143. Pandaranandaka J., Poonyachoti S., Kalandakanond-Thongsong S. Anxiolytic property of estrogen related to the changes of the monoamine levels in various brain regions of ovariectomized rats. Physiol Behav 2006, 87:828-835.
144. Pardridge W.M., Mietus L.J. Transport of steroid hormones through the rat blood-brain barrier. Primary role of albumin-bound hormone. J Clin Invest 1979, 64:145-154.
145. Pariante C.M., Lightman S.L. The HPA axis in major depression: classical theories and new developments. Trends Neurosci 2008, 31:464-468.
146. Parry B.L. Optimal management of perimenopausal depression. Int J Womens Health 2010, 2:143-151.
147. Parsey R.V., Hastings R.S., Oquendo M.A., Huang Y.Y., Simpson N., Arcement J., et al. Lower serotonin transporter binding potential in the human brain during major depressive episodes. Am J Psychiatry 2006, 163:52-58.
148. Pecins-Thompson M., Brown N.A., Bethea C.L. Regulation of serotonin re-uptake transporter mRNA expression by ovarian steroids in rhesus macaques. Brain Res Mol Brain Res 1998, 53:120-129.
149. Pérez S.E., Chen E.Y., Mufson E.J. Distribution of estrogen receptor alpha and beta immunoreactive profiles in the postnatal rat brain. Brain Res Dev Brain Res 2003, 145:117-139.
150. Perlman W.R., Webster M.J., Kleinman J.E., Weickert C.S. Reduced glucocorticoid and estrogen receptor alpha messenger ribonucleic acid levels in the amygdala of patients with major mental illness. Biol Psychiatry 2004, 56:844-852.
151. Pezawas L., Meyer-Lindenberg A., Drabant E.M., Verchinski B.A., Munoz K.E., Kolachana B.S., et al. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat Neurosci 2005, 8:828-834.
152. Piccinelli M., Wilkinson G. Gender differences in depression. Br J Psychiatry 2000, 177:486-492.
153. Pigott H.E., Leventhal A.M., Alter G.S., Boren J.J. Efficacy and effectiveness of antidepressants: current status of research. Psychother Psychosom 2010, 79:267-279.
154. Pio de Almeida L.S., Jansen K., Köhler C.A., Pinheiro R.T., da Silva R.A., Bonini J.S. Working and short-term memories are impaired in postpartum depression. J Affect Disord 2012, 136:1238-1242.
155. Pittenger C., Duman R.S. Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 2008, 33:88-109.
156. Prickaerts J., De Vry J., Boere J., Kenis G., Quinton M.S., Engel S., et al. Differential BDNF responses of triple versus dual reuptake inhibition in neuronal and astrocytoma cells as well as in rat hippocampus and prefrontal cortex. J Mol Neurosci 2012, 48:167-175.
157. Protopopescu X., Tuescher O., Pan H., Epstein J., Root J., Chang L., et al. Toward a functional neuroanatomy of premenstrual dysphoric disorder. J Affect Disord 2008, 108:87-94.
158. Puig M.V., Gulledge A.T. Serotonin and prefrontal cortex function: neurons, networks, and circuits. Mol Neurobiol 2011, 44:449-464.
159. 2A receptors. J Neurosci 2010, 30:2211-2222.
160. Rannevik G., Jeppsson S., Johnell O., Bjerre B., Laurell-Borulf Y., Svanberg L. A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas 2008, 61:67-77.
161. Rapkin A. A review of treatment of premenstrual syndrome and premenstrual dysphoric disorder. Psychoneuroendocrinology 2003, 28:39-53.
162. Rapp P.R., Morrison J.H., Roberts J.A. Cyclic estrogen replacement improves cognitive function in aged ovariectomized rhesus monkeys. J Neurosci 2003, 23:5708-5714.
163. Rasia-Filho A.A., Fabian C., Rigoti K.M., Achaval M. Influence of sex, estrous cycle and motherhood on dendritic spine density in the rat medial amygdala revealed by the Golgi method. Neuroscience 2004, 126:839-847.
164. 1A autoreceptor levels determine vulnerability to stress and response to antidepressants. Neuron 2010, 65:40-52.
165. Rigucci S., Serafini G., Pompili M., Kotzalidis G.D., Tatarelli R. Anatomical and functional correlates in major depressive disorder: the contribution of neuroimaging studies. World J Biol Psychiatry 2010, 11:165-180.
166. Rupp H.A., James T.W., Ketterson E.D., Sengelaub D.R., Ditzen B., Heiman J.R. Amygdala response to negative images in postpartum vs nulliparous women and intranasal oxytocin. Soc Cogn Affect Neurosci 2014, 9:48-54.
167. Ryan J., Ancelin M.L. Polymorphisms of estrogen receptors and risk of depression: therapeutic implications. Drugs 2012, 72:1725-1738.
168. Ryan J., Carrière I., Amieva H., Rouaud O., Berr C., Ritchie K., et al. Prospective analysis of the association between estrogen receptor gene variants and the risk of cognitive decline in elderly women. Eur Neuropsychopharmacol 2013, 23:1763-1768.
169. Saarelainen T., Hendolin P., Lucas G., Koponen E., Sairanen M., MacDonald E., et al. Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. J Neurosci 2003, 23:349-357.
170. Sánchez M.G., Morissette M., Di Paolo T. Oestradiol modulation of serotonin reuptake transporter and serotonin metabolism in the brain of monkeys. J Neuroendocrinol 2013, 25:560-569.
171. Sato K., Akaishi T., Matsuki N., Ohno Y., Nakazawa K. Beta-estradiol induces synaptogenesis in the hippocampus by enhancing brain-derived neurotrophic factor release from dentate gyrus granule cells. Brain Res 2007, 1150:108-120.
172. Savitz J., Lucki I., Drevets W.C. 5-HT(1A) receptor function in major depressive disorder. Prog Neurobiol 2009, 88:17-31.
173. Scharfman H.E., MacLusky N.J. Estrogen and brain-derived neurotrophic factor (BDNF) in hippocampus: complexity of steroid hormone-growth factor interactions in the adult CNS. Front Neuroendocrinol 2006, 27:415-435.
174. Schmidt P.J., Murphy J.H., Haq N., Danaceau M.A., St.Clair L. Basal plasma hormone levels in depressed perimenopausal women. Psychoneuroendocrinology 2002, 27:907-920.
175. Schneider L.S., Small G.W., Clary C.M. Estrogen replacement therapy and antidepressant response to sertraline in older depressed women. Am J Geriatr Psychiatry 2001, 9:393-399.
176. Sell S.L., Craft R.M., Seitz P.K., Stutz S.J., Cunningham K.A., Thomas M.L. Estradiol-sertraline synergy in ovariectomized rats. Psychoneuroendocrinology 2008, 33:1051-1060.
177. Shaywitz S.E., Shaywitz B.A., Pugh K.R., Fulbright R.K., Skudlarski P., Mencl W.E., et al. Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks. JAMA 1999, 281:1197-1202.
178. Sheng Z., Kawano J., Yanai A., Fujinaga R., Tanaka M., Watanabe Y., et al. Expression of estrogen receptors (α, β) and androgen receptor in serotonin neurons of the rat and mouse dorsal raphe nuclei; sex and species differences. Neurosci Res 2004, 49:185-196.
179. Sherman B.M., Korenman S.G. Hormonal characteristics of the human menstrual cycle throughout reproductive life. J Clin Invest 1975, 55:699-706.
180. Shirayama Y., Chen A.C., Nakagawa S., Russell D.S., Duman R.S. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 2002, 22:3251-3261.
181. Sichel D.A., Cohen L.S., Robertson L.M., Ruttenberg A., Rosenbaum J.F. Prophylactic estrogen in recurrent postpartum affective disorder. Biol Psychiatry 1995, 38:814-818.
182. Silverman M.E., Loudon H., Liu X., Mauro C., Leiter G., Goldstein M.A. The neural processing of negative emotion postpartum: a preliminary study of amygdala function in postpartum depression. Arch Womens Ment Health 2011, 14:355-359.
183. Sinopoli K.J., Floresco S.B., Galea L.A. Systemic and local administration of estradiol into the prefrontal cortex or hippocampus differentially alters working memory. Neurobiol Learn Mem 2006, 86:293-304.
184. Siuciak J.A., Boylan C., Fritsche M., Altar C.A., Lindsay R.M. BDNF increases monoaminergic activity in rat brain following intracerebroventricular or intraparenchymal administration. Brain Res 1996, 710:11-20.
185. Siuciak J.A., Clark M.S., Rind H.B., Whittemore S.R., Russo A.F. BDNF induction of tryptophan hydroxylase mRNA levels in the rat brain. J Neurosci Res 1998, 52:149-158.
186. Smith R., Chen K., Baxter L., Fort C., Lane R.D. Antidepressant effects of sertraline associated with volume increases in dorsolateral prefrontal cortex. J Affect Disord 2013, 146:414-419.
187. Soares C.N., Almeida O.P., Joffe H., Cohen L.S. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women. Arch Gen Psychiatry 2001, 58:529-534.
188. Soetanto A., Wilson R.S., Talbot K., Un A., Schneider J.A., Sobiesk M., et al. Association of anxiety and depression with microtubule-associated protein 2- and synaptopodin-immunolabeled dendrite and spine densities in hippocampal CA3 of older humans. Arch Gen Psychiatry 2010, 67:448-457.
189. Sohrabji F., Miranda R.C.G., Toran-Allerand C.D. Identification of a putative estrogen response element in the gene encoding brain-derived neurotrophic factor. Proc Natl Acad Sci U S A 1995, 92:11110-11114.
190. Spencer-Segal J.L., Tsuda M.C., Mattei L., Waters E.M., Romeo R.D., Milner T.A., McEwen B.S., Ogawa S. Estradiol acts via estrogen receptors alpha and beta on pathways important for synaptic plasticity in the mouse hippocampal formation. Neuroscience 2012, 202:131-146. 10.1016/j.
191. Steinberg E.M., Cardoso G.M., Martinez P.E., Rubinow D.R., Schmidt P.J. Rapid response to fluoxetine in women with premenstrual dysphoric disorder. Depress Anxiety 2012, 29:531-540.
192. Stewart D.E., Boydell K.M. Psychological distress during menopause: associations across the reproductive life cycle. Int J Psychiatry Med 1993, 23:157-162.
193. Stewart D.E., Robertson E., Dennis C.-L., Grace S.L., Wallington T. Postpartum depression: literature review of risk factors and interventions 2003, University Health Network Women's Health Program for Toronto Public Health, Toronto.
194. Sumner B.E., Fink G. Effects of acute estradiol on 5-hydroxytryptamine and dopamine receptor subtype mRNA expression in female rat brain. Mol Cell Neurosci 1993, 4:83-92.
195. Sumner B.E., Grant K.E., Rosie R., Hegele-Hartung C.H., Fritzemeier K.H., Fink G. Effects of tamoxifen on serotonin transporter and 5-hydroxytryptamine(2A) receptor binding sites and mRNA levels in the brain of ovariectomized rats with or without acute estradiol replacement. Brain Res Mol Brain Res 1999, 73:119-128.
196. Sumner B.E., Grant K.E., Rosie R., Hegele-Hartung C.H., Fritzemeier K.H., Fink G. Raloxifene blocks estradiol induction of the serotonin transporter and 5-hydroxytryptamine2A receptor in female rat brain. Neurosci Lett 2007, 417:95-99.
197. Suzuki H., Barros R.P., Sugiyama N., Krishnan V., Yaden B.C., Kim H.J., et al. Involvement of estrogen receptor β in maintenance of serotonergic neurons of the dorsal raphe. Mol Psychiatry 2013, 18:674-680.
198. 1a receptor proteins in the prefrontal cortex of subjects with major depressive disorder. Int J Neuropsychopharmacol 2009, 12:155-168.
199. Tellez R., Gómez-Viquez L., Liy-Salmeron G., Meneses A. GABA, glutamate, dopamine and serotonin transporters expression on forgetting. Neurobiol Learn Mem 2012, 98:66-77.
200. Tripp A., Oh H., Guilloux J.P., Martinowich K., Lewis D.A., Sibille E. Brain-derived neurotrophic factor signaling and subgenual anterior cingulate cortex dysfunction in major depressive disorder. Am J Psychiatry 2012, 169:1194-1202.
201. Tyler W.J., Alonso M., Bramham C.R., Pozzo-Miller L.D. From acquisition to consolidation: on the role of brain-derived neurotrophic factor signaling in hippocampal-dependent learning. Learn Mem 2002, 9:224-237.
202. Vassilopoulou K., Papathanasiou M., Michopoulos I., Boufidou F., Oulis P., Kelekis N., et al. A magnetic resonance imaging study of hippocampal, amygdala and subgenal prefrontal cortex volumes in major depression subtypes: melancholic versus psychotic depression. J Affect Disord 2013, 146:197-204.
203. Viguera A.C., Tondo L., Koukopoulos A.E., Reginaldi D., Lepri B., Baldessarini R.J. Episodes of mood disorders in 2,252 pregnancies and postpartum periods. Am J Psychiatry 2011, 168:1179-1185.
204. Walf A.A., Frye C.A. A review and update of mechanisms of estrogen in the hippocampus and amygdala for anxiety and depression behavior. Neuropsychopharmacology 2006, 31:1097-1111.
205. Wallace M., Luine V., Arellanos A., Frankfurt M. Ovariectomized rats show decreased recognition memory and spine density in the hippocampus and prefrontal cortex. Brain Res 2006, 1126:176-182.
206. Wang L., Peng D., Xie B., Jiang K., Fang Y. The extracellular signal-regulated kinase pathway may play an important role in mediating antidepressant-stimulated hippocampus neurogenesis in depression. Med Hypotheses 2012, 79:87-91.
207. Warner-Schmidt J.L., Duman R.S. VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants. Proc Natl Acad Sci U S A 2007, 104:4647-4652.
208. Weber M.T., Maki P.M., McDermott M.P. Cognition and mood in perimenopause: a systematic review and meta-analysis. J Steroid Biochem Mol Biol 2013, S0960-0760:111-118.
209. Weiser M.J., Foradori C.D., Handa R.J. Estrogen receptor beta in the brain: from form to function. Brain Res Rev 2008, 57:309-320.
210. Westlund T.L., Parry B.L. Does estrogen enhance the antidepressant effects of fluoxetine?. J Affect Disord 2003, 77:87-92.
211. Willard S.L., Daunais J.B., Cline J.M., Shively C.A. Hippocampal volume in postmenopausal cynomolgus macaques with behavioral depression. Menopause 2011, 18:582-586.
212. Woolley C.S., McEwen B.S. Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat. J Neurosci 1992, 12:2549-2554.
213. Yen J.Y., Chang S.J., Long C.Y., Tang T.C., Chen C.C., Yen C.F. Working memory deficit in premenstrual dysphoric disorder and its associations with difficulty in concentrating and irritability. Compr Psychiatry 2012, 53:540-545.
214. Young E.A., Kornstein S.G., Harvey A.T., Wisniewski S.R., Barkin J., Fava M., et al. Influences of hormone-based contraception on depressive symptoms in premenopausal women with major depression. Psychoneuroendocrinology 2007, 32:843-853.
215. Zeidan M.A., Igoe S.A., Linnman C., Vitalo A., Levine J.B., Klibanski A., et al. Estradiol modulates medial prefrontal cortex and amygdala activity during fear extinction in women and female rats. Biol Psychiatry 2011, 70:920-927.
216. Zhang J.Q., Cai W.Q., Zhou D.S., Su B.Y. Distribution and differences of estrogen receptor beta immunoreactivity in the brain of adult male and female rats. Brain Res 2002, 935:73-80.
217. Zhou J., Zhang H., Cohen R.S., Pandey S.C. Effects of estrogen treatment on expression of brain-derived neurotrophic factor and cAMP response element-binding protein expression and phosphorylation in rat amygdaloid and hippocampal structures. Neuroendocrinology 2005, 81:294-310.